CIK 0001626971
- Non-accelerated filer
- Smaller reporting company
Corvus Pharmaceuticals, Inc.
Sign in to watch- Ticker
- CRVS
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 464670809
- Phone
- +1 650-900-4520
- Business address
- 901 GATEWAY BLVD, THIRD FLOOR, SOUTH SAN FRANCISCO, CA, 94080
- Open-market buys, last 90 days
- $50,475
- in 1 filing
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$50,475. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-12-04 | LEA LEIV Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +400,000 | 400,000 | ||
| 2024-12-20 | LEA LEIV Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +300,000 | 300,000 | ||
| 2023-12-06 | LEA LEIV Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +200,000 | 200,000 | ||
| 2022-12-14 | LEA LEIV Chief Financial Officer | Purchase | +4,000 | $0.84 | $3K | 133,238 |
| 2022-12-13 | LEA LEIV Chief Financial Officer | Purchase | +30,000 | $0.74 | $22K | 129,238 |
| 2022-08-11 | LEA LEIV Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +160,000 | 160,000 | ||
| 2022-03-17 | LEA LEIV Chief Financial Officer | Purchase | +13,878 | $1.65 | $23K | 99,238 |
| 2022-03-16 | LEA LEIV Chief Financial Officer | Purchase | +35,160 | $1.54 | $54K | 85,360 |
| 2021-09-09 | LEA LEIV Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +160,000 | 160,000 | ||
| 2020-12-16 | LEA LEIV Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +160,000 | 160,000 | ||
| 2019-12-12 | LEA LEIV Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +160,000 | 160,000 | ||
| 2019-06-07 | LEA LEIV Chief Financial Officer | Purchase | +10,000 | $3.38 | $34K | 50,200 |
| 2019-06-06 | LEA LEIV Chief Financial Officer | Purchase | +15,500 | $3.56 | $55K | 40,200 |
| 2018-12-21 | LEA LEIV Chief Financial Officer | Purchase | +24,700 | $4.15 | $102K | 24,700 |
| 2018-12-12 | LEA LEIV Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +100,000 | 100,000 | ||
| 2017-12-13 | LEA LEIV Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +40,000 | 40,000 | ||
| 2016-12-07 | LEA LEIV Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +25,000 | 25,000 | ||
| 2016-03-29 | LEA LEIV Chief Financial Officer | Conversion | +42,608 | 199,253 | ||
| 2016-03-29 | LEA LEIV Chief Financial Officer | Conversion · Series A Preferred Stock | −42,608 | 0 | ||
| 2016-03-22 | LEA LEIV Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +60,000 | 60,000 |
Page 1 of 1 · 20 trades